Wednesday, August 26, 2026

MP Materials targets 10,000-tonne magnet output by 2028, tenfold scale-up from current capacity

MP Materials plans to commission its 10X magnet facility in 2028, expanding annual production from 1,000 to 10,000 metric tonnes. The scale-up addresses rare earth supply chain bottlenecks as U.S. manufacturers reduce China dependence. Increased magnet availability could pressure neodymium-praseodymium oxide prices while boosting domestic EV and defense production capacity.

MP Materials targets 10,000-tonne magnet output by 2028, tenfold scale-up from current capacity
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

MP Materials aims to commission its 10X magnet manufacturing facility in 2028, scaling annual output from 1,000 to 10,000 metric tonnes. The Fort Worth, Texas expansion represents the largest planned increase in Western rare earth magnet capacity this decade.

The company currently operates the only integrated rare earth mining and processing site in North America at Mountain Pass, California. Current production serves niche defense and industrial applications. The tenfold increase targets electric vehicle motors, wind turbines, and military systems.

Rare earth permanent magnets require neodymium, praseodymium, dysprosium, and terbium—elements where China controls 90% of global refining capacity. MP Materials' vertical integration from mine to magnet reduces supply chain exposure. The company extracts concentrate at Mountain Pass, processes oxides domestically, and will manufacture finished magnets in-house by 2028.

Market implications split across commodity and equity channels. Increased magnet supply could pressure neodymium-praseodymium oxide prices, which spiked to $160,000 per tonne in 2022 before settling near $50,000. Sustained production at 10,000 tonnes annually equals roughly 15% of current global magnet output, sufficient to move pricing if Chinese producers don't curtail supply.

Equity traders are watching rare earth miners and magnet consumers. Lynas Rare Earths and Energy Fuels compete in Western supply chains. Tesla, Rivian, and General Motors face magnet procurement constraints that limit EV scaling. Defense contractors Lockheed Martin and Raytheon depend on magnets for guidance systems and actuators.

The 2028 timeline carries execution risk. Magnet manufacturing requires sintering furnaces, coating lines, and quality control systems that have caused delays at other facilities. MP Materials hasn't disclosed capital expenditure for the 10X buildout, though comparable projects run $400-600 million.

Commissioning aligns with Inflation Reduction Act incentives for domestic EV supply chains. Automakers securing U.S.-sourced magnets gain tax credit eligibility, creating offtake demand before the facility starts. Forward contracts could lock pricing and validate the investment case ahead of first production.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· January 13, 2026
    Will the US’ onshoring strategy remove China’s chokehold on REEs?

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com